Document is current
Any future updates will be listed below
-
Authors
Li, Dan
Wang, Siquan
Jiang, Zhao
He, Fei
Zhang, Xiang
Zhu, Bingqing
Yang, Hongmei
Lv, Jing
Wang, Lei
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Hubei Province (2024AFB1046)
Peking University–Merck Joint Laboratory of Infectious Disease Prevention and Control Technology Medical Innovation Fund (10001202401)
the National Health Public Talent Program of the National Disease Control and Prevention Administration (S2025CF02)
Key Research and Development Program of China (2021YFC2301600)
- License Information
-
More Information
Article History
Received: 23 November 2025
Accepted: 24 February 2026
First Online: 26 March 2026
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could.
: The requirement of ethical approval was waived by Hubei Provincial Center for Disease Control and Prevention for the studies involving humans because meningococcal meningitis is a statutory infectious disease in China. The research involves meningococcal meningitis outbreak response and is exempt from ethical review according to the Law of the People’s Republic of China on Prevention and Control of Infectious Diseases. This exemption is in accordance with the Declaration of Helsinki.
: Not applicable
: This study involved public health outbreak response for a statutory infectious disease. All participants (or their guardians for minors) provided informed consent for epidemiological investigation, laboratory testing, and data collection. The study complied with the Declaration of Helsinki, and ethical approval was waived as per relevant regulations for infectious disease surveillance and response according to the Law of the People’s Republic of China on Prevention and Control of Infectious Diseases.
